Cargando…

Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions

G protein-coupled receptors (GPCRs) are involved in a plethora of different diseases. Consequently, these proteins are considered as an important class of drug targets. Measuring detailed kinetic information on these types of proteins has been challenging. Surface plasmon resonance (SPR) can provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonen, Arnaud, Singh, Abhimanyu K., Hout, Anneleen Van, Das, Kalyan, Loy, Tom Van, Noppen, Sam, Schols, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589327/
https://www.ncbi.nlm.nih.gov/pubmed/33096938
http://dx.doi.org/10.3390/bios10100150
_version_ 1783600553315532800
author Boonen, Arnaud
Singh, Abhimanyu K.
Hout, Anneleen Van
Das, Kalyan
Loy, Tom Van
Noppen, Sam
Schols, Dominique
author_facet Boonen, Arnaud
Singh, Abhimanyu K.
Hout, Anneleen Van
Das, Kalyan
Loy, Tom Van
Noppen, Sam
Schols, Dominique
author_sort Boonen, Arnaud
collection PubMed
description G protein-coupled receptors (GPCRs) are involved in a plethora of different diseases. Consequently, these proteins are considered as an important class of drug targets. Measuring detailed kinetic information on these types of proteins has been challenging. Surface plasmon resonance (SPR) can provide this information, however, the use of SPR on GPCRs remains a complex issue. Here, we report an SPR assay to investigate the interactions between the full-length chemokine receptor CXCR4 and nanobody-Fc (Nb-Fc) ligands. Nb-Fcs consist of two monovalent VHH domains fused with an Fc domain of a human IgG molecule. The CXCR4 protein used in this assay was produced with a C-terminal 10x-histidine tag and was immobilized on a nitrilotriacetic acid chip. In order to verify the sensitivity and effectiveness of this assay, the results were compared to data obtained from cellular assays as well as from another SPR assay using CXCR4 virus-like particles (VLPs). CXCR4 remained intact and stable for at least 12 h, and the kinetic results correlated well with both the cellular assays and the VLP SPR assay results. Apart from determining the binding kinetics of Nb-Fc with CXCR4, our results contributed to understanding CXCR4 interaction dynamics. In conclusion, this assay provides a viable experimental platform that has high potential to be expanded for studying other molecules as well as other histidine-tagged GPCRs.
format Online
Article
Text
id pubmed-7589327
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75893272020-10-29 Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions Boonen, Arnaud Singh, Abhimanyu K. Hout, Anneleen Van Das, Kalyan Loy, Tom Van Noppen, Sam Schols, Dominique Biosensors (Basel) Article G protein-coupled receptors (GPCRs) are involved in a plethora of different diseases. Consequently, these proteins are considered as an important class of drug targets. Measuring detailed kinetic information on these types of proteins has been challenging. Surface plasmon resonance (SPR) can provide this information, however, the use of SPR on GPCRs remains a complex issue. Here, we report an SPR assay to investigate the interactions between the full-length chemokine receptor CXCR4 and nanobody-Fc (Nb-Fc) ligands. Nb-Fcs consist of two monovalent VHH domains fused with an Fc domain of a human IgG molecule. The CXCR4 protein used in this assay was produced with a C-terminal 10x-histidine tag and was immobilized on a nitrilotriacetic acid chip. In order to verify the sensitivity and effectiveness of this assay, the results were compared to data obtained from cellular assays as well as from another SPR assay using CXCR4 virus-like particles (VLPs). CXCR4 remained intact and stable for at least 12 h, and the kinetic results correlated well with both the cellular assays and the VLP SPR assay results. Apart from determining the binding kinetics of Nb-Fc with CXCR4, our results contributed to understanding CXCR4 interaction dynamics. In conclusion, this assay provides a viable experimental platform that has high potential to be expanded for studying other molecules as well as other histidine-tagged GPCRs. MDPI 2020-10-21 /pmc/articles/PMC7589327/ /pubmed/33096938 http://dx.doi.org/10.3390/bios10100150 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Boonen, Arnaud
Singh, Abhimanyu K.
Hout, Anneleen Van
Das, Kalyan
Loy, Tom Van
Noppen, Sam
Schols, Dominique
Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions
title Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions
title_full Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions
title_fullStr Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions
title_full_unstemmed Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions
title_short Development of a Novel SPR Assay to Study CXCR4–Ligand Interactions
title_sort development of a novel spr assay to study cxcr4–ligand interactions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589327/
https://www.ncbi.nlm.nih.gov/pubmed/33096938
http://dx.doi.org/10.3390/bios10100150
work_keys_str_mv AT boonenarnaud developmentofanovelsprassaytostudycxcr4ligandinteractions
AT singhabhimanyuk developmentofanovelsprassaytostudycxcr4ligandinteractions
AT houtanneleenvan developmentofanovelsprassaytostudycxcr4ligandinteractions
AT daskalyan developmentofanovelsprassaytostudycxcr4ligandinteractions
AT loytomvan developmentofanovelsprassaytostudycxcr4ligandinteractions
AT noppensam developmentofanovelsprassaytostudycxcr4ligandinteractions
AT scholsdominique developmentofanovelsprassaytostudycxcr4ligandinteractions